Search Results

There are 2482 results for: content related to: Role of immunmodulators in allergen-specific immunotherapy

  1. You have free access to this content
    Omalizumab for asthma in adults and children

    Intervention Review

    The Cochrane Library

    Rebecca Normansell, Samantha Walker, Stephen J Milan, E. Haydn Walters and Parameswaran Nair

    Published Online : 13 JAN 2014, DOI: 10.1002/14651858.CD003559.pub4

  2. Anti-IgE in Persistent Severe Allergic Asthma

    Allergy and Allergic Diseases, Volume 1, Second Edition

    Marc Humbert, Stephen T. Holgate, Howard Fox, Jean Bousquet, Pages: 1661–1686, 2009

    Published Online : 10 FEB 2009, DOI: 10.1002/9781444300918.ch81

  3. You have free access to this content
    EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

    Allergy

    Volume 70, Issue 7, July 2015, Pages: 727–754, O. Boyman, C. Kaegi, M. Akdis, S. Bavbek, A. Bossios, A. Chatzipetrou, T. Eiwegger, D. Firinu, T. Harr, E. Knol, A. Matucci, O. Palomares, C. Schmidt-Weber, H.-U. Simon, U. C. Steiner, A. Vultaggio, C. A. Akdis and F. Spertini

    Version of Record online : 24 APR 2015, DOI: 10.1111/all.12616

  4. Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Accepted manuscript online: 22 FEB 2017, Alessandro Tonacci, Lucia Billeci, Giovanni Pioggia, Michele Navarra and Sebastiano Gangemi

    DOI: 10.1002/phar.1915

  5. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy

    Clinical & Experimental Allergy

    Volume 35, Issue 4, April 2005, Pages: 408–416, S. T. Holgate, R. Djukanović, T. Casale and J. Bousquet

    Version of Record online : 11 APR 2005, DOI: 10.1111/j.1365-2222.2005.02191.x

  6. You have free access to this content
    An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma

    Allergy

    Volume 63, Issue 6, June 2008, Pages: 670–684, S. D. Sullivan and F. Turk

    Version of Record online : 25 APR 2008, DOI: 10.1111/j.1398-9995.2008.01723.x

  7. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy

    Pediatric Allergy and Immunology

    Volume 24, Issue 5, August 2013, Pages: 427–433, Matthias Volkmar Kopp, Eckard Hamelmann, Meike Bendiks, Stefan Zielen, Wolfgang Kamin, Karl-Christian Bergmann, Christian Klein, Ulrich Wahn and for The DUAL study group

    Version of Record online : 25 JUN 2013, DOI: 10.1111/pai.12098

  8. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients

    Pediatric Pulmonology

    Volume 52, Issue 2, February 2017, Pages: 190–197, Raphaële Nové-Josserand, Soazic Grard, Lila Auzou, Philippe Reix, Marlène Murris-Espin, François Brémont, Benyebka Mammar, Laurent Mely, Dominique Hubert, Isabelle Durieu and Pierre-Régis Burgel

    Version of Record online : 7 OCT 2016, DOI: 10.1002/ppul.23612

  9. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective

    Allergy

    Volume 65, Issue 9, September 2010, Pages: 1141–1148, J. D. Campbell, D. E. Spackman and S. D. Sullivan

    Version of Record online : 10 FEB 2010, DOI: 10.1111/j.1398-9995.2010.02336.x

  10. You have free access to this content
    ‘Real-life’ effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review

    Allergy

    Volume 71, Issue 5, May 2016, Pages: 593–610, I. Abraham, A. Alhossan, C. S. Lee, H. Kutbi and K. MacDonald

    Version of Record online : 25 FEB 2016, DOI: 10.1111/all.12815

  11. You have free access to this content
    Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria

    Journal of the European Academy of Dermatology and Venereology

    Volume 30, Issue S5, July 2016, Pages: 25–32, A. M. Giménez-Arnau, E. Toubi, A. M. Marsland and M. Maurer

    Version of Record online : 10 JUN 2016, DOI: 10.1111/jdv.13697

  12. Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment

    British Journal of Dermatology

    Volume 173, Issue 2, August 2015, Pages: 404–415, M.C. Urgert, M.T. van den Elzen, A.C. Knulst, Z. Fedorowicz and E.J. van Zuuren

    Version of Record online : 22 JUL 2015, DOI: 10.1111/bjd.13845

  13. You have free access to this content
    Management and treatment of chronic urticaria (CU)

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue S3, June 2015, Pages: 16–32, M. Maurer, M.K. Church, M. Gonçalo, G. Sussman and M. Sánchez-Borges

    Version of Record online : 4 JUN 2015, DOI: 10.1111/jdv.13198

  14. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR

    Allergy

    Volume 59, Issue 7, July 2004, Pages: 709–717, A. M. Vignola, M. Humbert, J. Bousquet, L-P. Boulet, S. Hedgecock, M. Blogg, H. Fox and K. Surrey

    Version of Record online : 4 JUN 2004, DOI: 10.1111/j.1398-9995.2004.00550.x

  15. Individually dosed omalizumab: an effective treatment for severe peanut allergy

    Clinical & Experimental Allergy

    J. Brandström, M. Vetander, G. Lilja, S. G. O. Johansson, A.-C. Sundqvist, F. Kalm, C. Nilsson and A. Nopp

    Version of Record online : 10 JAN 2017, DOI: 10.1111/cea.12862

  16. Omalizumab (Xolair): Anti-Immunoglobulin E Treatment in Allergic Diseases

    Handbook of Therapeutic Antibodies

    Claus Kroegel, Martin Foerster, Pages: 951–997, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch37

  17. Omalizumab may not inhibit mast cell and basophil activation in vitro

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 9, September 2015, Pages: 1832–1836, J. Gericke, T. Ohanyan, M.K. Church, M. Maurer and M. Metz

    Version of Record online : 26 SEP 2014, DOI: 10.1111/jdv.12693

  18. Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis

    Clinical & Experimental Allergy

    Volume 38, Issue 2, February 2008, Pages: 329–337, T. Nagakura, S. Ogino, K. Okubo, N. Sato, M. Takahashi and T. Ishikawa

    Version of Record online : 7 DEC 2007, DOI: 10.1111/j.1365-2222.2007.02894.x

  19. You have free access to this content
    Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria

    Allergy

    A. P. Kaplan, A. M. Giménez-Arnau and S. S. Saini

    Version of Record online : 4 JAN 2017, DOI: 10.1111/all.13083

  20. Immunoglobulin E Blockade in the Treatment of Asthma

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 10, October 2007, Pages: 1412–1424, Robert Kuhn

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.10.1412